US Stock MarketDetailed Quotes

Corbus Pharmaceuticals (CRBP)

Watchlist
  • 8.170
  • -0.090-1.09%
Close Jan 15 16:00 ET
  • 8.000
  • -0.170-2.08%
Post 19:47 ET
143.41MMarket Cap-1.49P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corbus Pharmaceuticals (CRBP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
57.48%24.42M
74.30%19.15M
105.50%19.78M
8.08%48.72M
24.75%12.61M
63.42%15.51M
34.18%10.99M
-44.37%9.62M
29.40%45.08M
-6.42%10.1M
Selling and administrative expenses
-24.27%3.56M
-3.83%3.97M
7.04%4.13M
18.61%16.5M
22.22%3.82M
59.93%4.7M
4.64%4.12M
-1.22%3.86M
-25.61%13.91M
-31.40%3.12M
-General and administrative expense
-24.27%3.56M
-3.83%3.97M
7.04%4.13M
18.61%16.5M
22.22%3.82M
59.93%4.7M
4.64%4.12M
-1.22%3.86M
-25.61%13.91M
-31.40%3.12M
Research and development costs
93.01%20.86M
121.22%15.19M
171.47%15.64M
3.38%32.22M
25.89%8.79M
64.98%10.81M
61.57%6.87M
-56.96%5.76M
93.15%31.17M
11.81%6.98M
Operating profit
-57.48%-24.42M
-74.30%-19.15M
-105.50%-19.78M
-8.08%-48.72M
-24.75%-12.61M
-63.42%-15.51M
-34.18%-10.99M
44.37%-9.62M
-29.40%-45.08M
6.42%-10.1M
Net non-operating interest income expense
-26.08%1.13M
38.61%1.31M
789.42%1.68M
299.77%4.44M
35,700.00%1.78M
299.48%1.52M
222.16%948K
127.88%189K
-4.22%-2.22M
99.22%-5K
Non-operating interest income
-40.88%1.13M
-17.88%1.31M
63.52%1.68M
285.76%6.31M
92.43%1.78M
776.96%1.9M
589.66%1.6M
--1.03M
--1.64M
--925K
Non-operating interest expense
--0
--0
--0
-51.48%1.87M
--0
-61.12%381K
-35.32%652K
--839K
--3.86M
--930K
Total other finance cost
----
----
----
----
----
----
----
-73.89%177.02K
----
----
Other net income (expense)
-125.00%-50K
309.30%176K
-55.98%1.12M
51.08%4.07M
-37.95%1.3M
1.01%200K
-76.24%43K
1,001.05%2.54M
150.12%2.7M
273.53%2.09M
Gain on sale of security
----
----
----
----
----
1,105.00%201K
2,200.00%42K
-1,213.74%-8.11K
----
----
Other non- operating income (expenses)
-125.00%-50K
309.30%176K
-55.98%1.12M
51.08%4.07M
-37.32%1.3M
-8.26%200K
-76.50%43K
1,004.54%2.54M
5,627.65%2.7M
649.78%2.07M
Income before tax
-69.35%-23.34M
-76.67%-17.66M
-146.09%-16.98M
9.85%-40.21M
-18.80%-9.53M
-37.10%-13.78M
-13.81%-10M
61.12%-6.9M
-5.33%-44.6M
26.26%-8.02M
Income tax
Net income
-69.35%-23.34M
-76.67%-17.66M
-146.09%-16.98M
9.85%-40.21M
-18.80%-9.53M
-37.10%-13.78M
-13.81%-10M
61.12%-6.9M
-5.33%-44.6M
26.26%-8.02M
Net income continuous Operations
-69.35%-23.34M
-76.67%-17.66M
-146.09%-16.98M
9.85%-40.21M
-18.80%-9.53M
-37.10%-13.78M
-13.81%-10M
61.12%-6.9M
-5.33%-44.6M
26.26%-8.02M
Minority interest income
Net income attributable to the parent company
-69.35%-23.34M
-76.67%-17.66M
-146.09%-16.98M
9.85%-40.21M
-18.80%-9.53M
-37.10%-13.78M
-13.81%-10M
61.12%-6.9M
-5.33%-44.6M
26.26%-8.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-69.35%-23.34M
-76.67%-17.66M
-146.09%-16.98M
9.85%-40.21M
-18.80%-9.53M
-37.10%-13.78M
-13.81%-10M
61.12%-6.9M
-5.33%-44.6M
26.26%-8.02M
Basic earnings per share
-65.22%-1.9
-60.00%-1.44
-67.47%-1.39
64.31%-3.68
56.42%-0.78
49.34%-1.15
56.10%-0.9
80.42%-0.83
-1.58%-10.31
31.42%-1.79
Diluted earnings per share
-65.22%-1.9
-60.00%-1.44
-67.47%-1.39
64.31%-3.68
56.42%-0.78
49.34%-1.15
56.10%-0.9
80.42%-0.83
-1.58%-10.31
31.42%-1.79
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 57.48%24.42M74.30%19.15M105.50%19.78M8.08%48.72M24.75%12.61M63.42%15.51M34.18%10.99M-44.37%9.62M29.40%45.08M-6.42%10.1M
Selling and administrative expenses -24.27%3.56M-3.83%3.97M7.04%4.13M18.61%16.5M22.22%3.82M59.93%4.7M4.64%4.12M-1.22%3.86M-25.61%13.91M-31.40%3.12M
-General and administrative expense -24.27%3.56M-3.83%3.97M7.04%4.13M18.61%16.5M22.22%3.82M59.93%4.7M4.64%4.12M-1.22%3.86M-25.61%13.91M-31.40%3.12M
Research and development costs 93.01%20.86M121.22%15.19M171.47%15.64M3.38%32.22M25.89%8.79M64.98%10.81M61.57%6.87M-56.96%5.76M93.15%31.17M11.81%6.98M
Operating profit -57.48%-24.42M-74.30%-19.15M-105.50%-19.78M-8.08%-48.72M-24.75%-12.61M-63.42%-15.51M-34.18%-10.99M44.37%-9.62M-29.40%-45.08M6.42%-10.1M
Net non-operating interest income expense -26.08%1.13M38.61%1.31M789.42%1.68M299.77%4.44M35,700.00%1.78M299.48%1.52M222.16%948K127.88%189K-4.22%-2.22M99.22%-5K
Non-operating interest income -40.88%1.13M-17.88%1.31M63.52%1.68M285.76%6.31M92.43%1.78M776.96%1.9M589.66%1.6M--1.03M--1.64M--925K
Non-operating interest expense --0--0--0-51.48%1.87M--0-61.12%381K-35.32%652K--839K--3.86M--930K
Total other finance cost -----------------------------73.89%177.02K--------
Other net income (expense) -125.00%-50K309.30%176K-55.98%1.12M51.08%4.07M-37.95%1.3M1.01%200K-76.24%43K1,001.05%2.54M150.12%2.7M273.53%2.09M
Gain on sale of security --------------------1,105.00%201K2,200.00%42K-1,213.74%-8.11K--------
Other non- operating income (expenses) -125.00%-50K309.30%176K-55.98%1.12M51.08%4.07M-37.32%1.3M-8.26%200K-76.50%43K1,004.54%2.54M5,627.65%2.7M649.78%2.07M
Income before tax -69.35%-23.34M-76.67%-17.66M-146.09%-16.98M9.85%-40.21M-18.80%-9.53M-37.10%-13.78M-13.81%-10M61.12%-6.9M-5.33%-44.6M26.26%-8.02M
Income tax
Net income -69.35%-23.34M-76.67%-17.66M-146.09%-16.98M9.85%-40.21M-18.80%-9.53M-37.10%-13.78M-13.81%-10M61.12%-6.9M-5.33%-44.6M26.26%-8.02M
Net income continuous Operations -69.35%-23.34M-76.67%-17.66M-146.09%-16.98M9.85%-40.21M-18.80%-9.53M-37.10%-13.78M-13.81%-10M61.12%-6.9M-5.33%-44.6M26.26%-8.02M
Minority interest income
Net income attributable to the parent company -69.35%-23.34M-76.67%-17.66M-146.09%-16.98M9.85%-40.21M-18.80%-9.53M-37.10%-13.78M-13.81%-10M61.12%-6.9M-5.33%-44.6M26.26%-8.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -69.35%-23.34M-76.67%-17.66M-146.09%-16.98M9.85%-40.21M-18.80%-9.53M-37.10%-13.78M-13.81%-10M61.12%-6.9M-5.33%-44.6M26.26%-8.02M
Basic earnings per share -65.22%-1.9-60.00%-1.44-67.47%-1.3964.31%-3.6856.42%-0.7849.34%-1.1556.10%-0.980.42%-0.83-1.58%-10.3131.42%-1.79
Diluted earnings per share -65.22%-1.9-60.00%-1.44-67.47%-1.3964.31%-3.6856.42%-0.7849.34%-1.1556.10%-0.980.42%-0.83-1.58%-10.3131.42%-1.79
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -